EMA Authorised: Palynziq (pegvaliase) — BioMarin International Limited

View source ↗

Summary

The European Medicines Agency authorised Palynziq (pegvaliase) by BioMarin International Limited for phenylketonuria, with orphan medicine designation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• PALYNZIQ (PEGVALIASE-PQPZ)

Snippet

Status: Authorised. Therapeutic area: Phenylketonurias. MAH: BioMarin International Limited. Decision date: 19/04/2024. Orphan medicine